share_log

Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(8.67%),Deep Track Biotechnology Master Fund, Ltd.(8.67%), etc.

Autolus Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(8.67%),Deep Track Biotechnology Master Fund, Ltd.(8.67%)等

2023/02/14 08:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息